The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

Abstract: Nowadays, as the demand for accurate object detection (OD) applications is increasing, several attempts have been made to introduce convolutional neural network (CNN)-based super-resolution ...

With the holidays are just around the corner, your savings might be taking a hit. Why not take a shot at one of the year's biggest Powerball jackpots? Saturday's prize has reached $1 billion and while ...

Abstract: Handwritten digit recognition using deep learning models is an active area of research with wide-ranging applications. However, the high computational requirements of these models limit ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...